Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs Quanta Services Inc (PWR) Price & Performance

CVS Health CorpTrade
Quanta Services IncTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs Quanta Services Inc — how do they compare? CVS Health Corp trades at $86.85 (market cap $112.49B), while Quanta Services Inc trades at $690.88 (market cap $105.40B). The key difference: CVS Health Corp and Quanta Services Inc are close in size by market cap, and CVS Health Corp pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Quanta Services Inc for 62 Days on average.

CVSPWR
Market Cap
$112.49B$105.40B
Volume
8,467,3921,014,408
Sector
HealthIndustrials
52-Week High
$110.60$785.24
52-Week Low
$70.08$412.21
Typical Hold Time
83 Days62 Days
Enterprise Value
$174.83B$111.50B
Dividend Yield
3.02%0.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.

CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.

Quanta Services Inc

Quanta Services (PWR) trades at $685.33, down 4.76% on the day, but maintains a bullish technical trend with strong analyst support. Revenue growth is robust, climbing from $17.1B in 2022 to $28.5B in 2025, with net income reaching $1.03B. The company benefits from a record $53B backlog and positive earnings surprises, though valuation multiples like a P/E of 80.21 suggest premium pricing. Recent news highlights PWR's role in AI infrastructure and data center spending, driving investor optimism.

Outlook remains positive given strong earnings beats and sector tailwinds, but high valuation and execution risks from rapid expansion pose challenges. Analysts see 26.5% upside to a $802.08 consensus target, with no sell ratings. Risks include margin pressure and macroeconomic sensitivity, yet institutional bullishness and operational momentum support long-term growth potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVS

No sentiment data available yet.

PWR
25% Buy75% Sell
Avg holding period · 62 Days

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS →

About Quanta Services Inc

Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.

Read more on PWR →